Compare · BFLY vs NNOX
BFLY vs NNOX
Side-by-side comparison of Butterfly Network Inc. (BFLY) and NANO-X IMAGING LTD (NNOX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BFLY and NNOX operate in Medical Electronics (Health Care), so they compete in similar markets.
- BFLY is the larger of the two at $1.73B, about 22.2x NNOX ($77.9M).
- Over the past year, BFLY is up 255.6% and NNOX is down 77.8% - BFLY leads by 333.5 points.
- BFLY has been more active in the news (22 items in the past 4 weeks vs 3 for NNOX).
- BFLY has more recent analyst coverage (8 ratings vs 4 for NNOX).
- Company
- Butterfly Network Inc.
- NANO-X IMAGING LTD
- Price
- $6.62-5.63%
- $1.14+5.56%
- Market cap
- $1.73B
- $77.9M
- 1M return
- +17.08%
- -33.72%
- 1Y return
- +255.65%
- -77.82%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- 2020
- News (4w)
- 22
- 3
- Recent ratings
- 8
- 4
Butterfly Network Inc.
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.
NANO-X IMAGING LTD
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.
Latest BFLY
- SEC Form 144 filed by Butterfly Network Inc.
- Amendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.
- Director Rothberg Jonathan M sold $20,765,302 worth of shares (2,799,818 units at $7.42) as part of a pre-agreed trading plan and sold $8,603,330 worth of Class B Common Stock (1,213,634 units at $7.09) as part of a pre-agreed trading plan, decreasing direct ownership by 96% to 105,881 units (SEC Form 4)
- SEC Form 144 filed by Butterfly Network Inc.
- Butterfly Network to Report Second Quarter 2026 Financial Results on July 30, 2026
- SEC Form 144 filed by Butterfly Network Inc.
- SEC Form 144 filed by Butterfly Network Inc.
- Chief Technology Officer Ku Victor sold $280,665 worth of shares (35,649 units at $7.87), decreasing direct ownership by 3% to 1,063,639 units (SEC Form 4) to cover taxes
- EVP, CFO Doherty John N. sold $434,818 worth of shares (55,229 units at $7.87), decreasing direct ownership by 4% to 1,454,412 units (SEC Form 4) to satisfy withholding tax
- President & CEO Devivo Joseph sold $1,611,800 worth of shares (204,725 units at $7.87), decreasing direct ownership by 3% to 7,883,844 units (SEC Form 4) (tax withholding)
Latest NNOX
- Nano-X Imaging downgraded by Alliance Global Partners with a new price target
- New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026
- SEC Form 6-K filed by NANO-X IMAGING LTD
- Director Alroy Erez sold $1,119 worth of Ordinary Shares (678 units at $1.65), increasing direct ownership by 145% to 17,075 units (SEC Form 4)
- Nanox to Report First Quarter 2026 Financial Results on June 25, 2026
- Exclusive distribution agreement marks Nanox's entry into the Peruvian market
- Amendment: SEC Form SCHEDULE 13G/A filed by NANO-X IMAGING LTD
- Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
- Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems
- SEC Form 20-F filed by NANO-X IMAGING LTD